Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab

Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab

Purpose Mogamulizumab demonstrated improved outcomes vs. vorinostat across a range of disease and patient characteristics in patients with mycosis fungoides or Sézary syndrome in the MAVORIC trial.Materials and methods This post-hoc analysis further examined MAVORIC data to assess factors associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Francine Foss, Youn H. Kim, Julia Scarisbrick, Oleg Akilov, Robert Ristuccia, Karen Dwyer, Wende Wu, Martine Bagot
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Dermatological Treatment
Subjects:
Cutaneous T-cell lymphoma
mycosis fungoides
Sézary syndrome
mogamulizumab
C-C chemokine receptor 4
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2438794
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2024.2438794

Similar Items